In the current trading session, Caredx Inc’s (CDNA) stock is trading at the price of $13.88, a fall of -1.03% over last night’s close. So, the stock is trading at a price that is -57.91% less than its 52-week high of $32.97 and 26.60% better than its 52-week low of $10.96.
It is also essential to consider CDNA stock ratios like the price-to-sales ratio, which is 2.17 for the last year.Likewise, its price to free cash flow for the last twelve months stands at 62.17. CDNA’s price to book ratio for the most recent quarter was 2.26, resulting in an 3.97 price to cash per share for the period.
How does Caredx Inc (CDNA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Caredx Inc (CDNA): Earnings History
If we examine Caredx Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of $0.1, beating the consensus of $0.12. In other words, it topped the consensus by -$0.02, resulting in a -18.03% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of $0.1 in contrast with the Outlook of $0.12. That was a difference of -$0.02 and a surprise of -18.03%.
Caredx Inc (NASDAQ: CDNA) Ownership Details
I will give a breakdown of the key shareholders in Caredx Inc (CDNA). Recent figures show that the company’s insiders hold 3.51% of shares. A total of 284 institutional investors hold shares in the company, making 101.58% of its stock and 105.28% of its float.
Jul 31, 2025, it was reported that the Company’s largest institutional holder is ARK ETF Trust-ARK Genomic Revolution ETF holding total of 2.06 shares that make 3.88% of the company’s total number of shares and are currently priced at 28.91 million.
The securities firm BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. holds 1.82 shares of CDNA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 3.42%, and the holding percentage of shares is valued at 25.5 million.
